Researchers recently detailed a new pancreatic cancer test that detects microRNAs in whole blood in a study published in The Journal of the American Medical Association.
The test is designed to detect biomarkers for early diagnosis of pancreatic cancer, improving patients' prognosis.
The study classified two diagnostic panels based on microRNAs in whole blood.
More Articles on Gastroenterology:
Looking Beyond the Scope: Integrated Care & Women's Health in Gastroenterology
Cost-Effective Question: FMT vs. Antibiotics
6 Statistics on Colorectal Cancer Diagnosis & Mortality
The test is designed to detect biomarkers for early diagnosis of pancreatic cancer, improving patients' prognosis.
The study classified two diagnostic panels based on microRNAs in whole blood.
More Articles on Gastroenterology:
Looking Beyond the Scope: Integrated Care & Women's Health in Gastroenterology
Cost-Effective Question: FMT vs. Antibiotics
6 Statistics on Colorectal Cancer Diagnosis & Mortality